SJS Investment Consulting’s Globus Medical GMED Stock Holding History

SJS Investment Consulting’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.7K	Sell	388 -70	-15%	-$5.95K	﹤0.01%	636
2026 Q1	$39.5K	Buy	458 +64	+16%	+$5.74K	﹤0.01%	471
2025 Q4	$34.4K	Sell	394 -1	-0.3%	-$76	﹤0.01%	478
2025 Q3	$22.6K	Buy	395 +384	+3,491%	+$22.1K	﹤0.01%	503
2025 Q2	$650	Hold	11	–	–	﹤0.01%	1021
2025 Q1	$806	Buy	+11	New	+$909	﹤0.01%	1075
2024 Q2	–	Sell	-5	Closed	-$269	–	1687
2024 Q1	$269	Sell	5 -10	-67%	-$538	﹤0.01%	1435
2023 Q4	$800	Hold	15	–	–	﹤0.01%	1048
2023 Q3	$745	Buy	15 +4	+36%	+$224	﹤0.01%	1051
2023 Q2	$655	Buy	11 +9	+450%	+$513	﹤0.01%	1062
2023 Q1	$114	Sell	2 -11	-85%	-$705	﹤0.01%	1447
2022 Q4	$966	Buy	13 +1	+8%	+$68	﹤0.01%	947
2022 Q3	$0	Buy	+12	New	+$723	﹤0.01%	1217
2022 Q1	$0	Buy	+1	New	+$70	﹤0.01%	946

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

SJS Investment Consulting's GMED Position: Q2 2026 in Review

SJS Investment Consulting reduced its Globus Medical (GMED) stake by 15% in Q2 2026, selling an estimated $5.95K and leaving 388 shares worth $30.7K. The position accounts for ﹤0.01% of the portfolio, ranked #636.

SJS Investment Consulting first reported a position in GMED in Q1 2022 and has held it in 14 quarters since. The position peaked at $39.5K in Q1 2026. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

SJS Investment Consulting held 388 shares of Globus Medical worth $30.7K as of Q2 2026.
SJS Investment Consulting sold 70 Globus Medical shares in Q2 2026, an estimated $5.95K.
Globus Medical made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #636 holding.
SJS Investment Consulting first reported a position in Globus Medical in Q1 2022 and has held it in 14 quarters since.
SJS Investment Consulting's Globus Medical position peaked at $39.5K in Q1 2026.
601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.